Biotech Values

[turtlepower]

I assume you are referring to the 1st line trial where ogx-011+tax showed a 6 month improvement over tax alone. I don't believe they ran a similar controlled trial for 2nd line. If I remember correctly the 2nd line PII trial they ran had 011+tax in one arm and 011+another chemo in the other. Since the 011 trial was in 1st line its difficult to compare the outcome of that trial with that of the abiraterone trial.